Literature DB >> 14696405

Preserved function of the Oddi sphincter after endoscopic papillary balloon dilation.

Hiroyuki Isayama1, Yutaka Komatsu, Yusuke Inoue, Nobuo Toda, Yasushi Shiratori, Takeshi Tsujino, Hisashi Yamada, Keiji Saitou, Takao Kawabe, Masao Omata.   

Abstract

BACKGROUND/AIMS: Endoscopic papillary balloon dilation (EPBD) is a safe and effective procedure for the treatment of bile duct stones that appears to be less hazardous to the sphincter of Oddi than endoscopic sphincterotomy. However, little is known about the function of Oddi muscle after EPBD. The aim of the present study is to evaluate Oddi muscle function using quantitative cholescintigraphy.
METHODOLOGY: This study was conducted using 12 patients treated for bile duct stones by EPBD, and 8 patients treated by endoscopic sphincterotomy, followed by laparoscopic cholecystectomy thereafter. For the controls, 10 asymptomatic cholecystectomized patients were used. From 1-3 years after the interventional procedures, patients received a quantitative cholescintigraphy examination using 185 MBq of technetium-99m-N-pyridoxyl-5-methyl-tryptophan. The hepatic hilum-duodenum transit time on quantitative cholescintigraphy was measured as the time interval between the initial appearance of isotope activity at the hepatic hilum and that at the duodenum.
RESULTS: Mean hilum-duodenum transit time in patients after EPBD (6.3 min, 95%CI 4.5-8.0) was not different from that in control patients (6.5 min, 95%CI 4.3-8.7), whereas mean hilum-duodenum transit time in endoscopic sphincterotomy patients (3.2 min, 95%CI 2.4-4.0) was markedly shorter than both the control and EPBD groups (p = 0.0053).
CONCLUSIONS: The function of the sphincter of Oddi may be preserved after endoscopic papillary balloon dilation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14696405

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  16 in total

1.  Cholecystectomy after endoscopic papillary balloon dilation for bile duct stones reduced late biliary complications: a propensity score-based cohort analysis.

Authors:  Yousuke Nakai; Hiroyuki Isayama; Takeshi Tsujino; Tsuyoshi Hamada; Hirofumi Kogure; Naminatsu Takahara; Dai Mohri; Saburo Matsubara; Natsuyo Yamamoto; Minoru Tada; Kazuhiko Koike
Journal:  Surg Endosc       Date:  2015-10-20       Impact factor: 4.584

2.  The ballooning time in endoscopic papillary balloon dilation for the treatment of bile duct stones.

Authors:  Byoung Wook Bang; Seok Jeong; Don Haeng Lee; Jung Il Lee; Jin-Woo Lee; Kye Sook Kwon; Hyung Gil Kim; Yong Woon Shin; Young Soo Kim
Journal:  Korean J Intern Med       Date:  2010-08-31       Impact factor: 2.884

3.  Endoscopic papillary balloon dilation for bile duct stone removal in patients 60 years old or younger.

Authors:  Takeshi Tsujino; Haruhiko Yoshida; Hiroyuki Isayama; Yukiko Ito; Yoko Yashima; Hiroshi Yagioka; Hirofumi Kogure; Takashi Sasaki; Toshihiko Arizumi; Osamu Togawa; Saburo Matsubara; Yousuke Nakai; Naoki Sasahira; Kenji Hirano; Minoru Tada; Takao Kawabe; Masao Omata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2010-05-14       Impact factor: 7.527

Review 4.  Endoscopic management of biliary strictures after living donor liver transplantation.

Authors:  Takeshi Tsujino; Hiroyuki Isayama; Hirofumi Kogure; Tatsuya Sato; Yousuke Nakai; Kazuhiko Koike
Journal:  Clin J Gastroenterol       Date:  2017-06-09

5.  Endoscopic papillary balloon dilation for bile duct stones in patients on hemodialysis.

Authors:  Naminatsu Takahara; Hiroyuki Isayama; Takashi Sasaki; Takeshi Tsujino; Nobuo Toda; Naoki Sasahira; Suguru Mizuno; Kazumichi Kawakubo; Hirofumi Kogure; Natsuyo Yamamoto; Yousuke Nakai; Kenji Hirano; Minoru Tada; Masao Omata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2012-02-22       Impact factor: 7.527

Review 6.  Balloon dilation itself may not be a major determinant of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Sung Ill Jang; Gak Won Yun; Dong Ki Lee
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 7.  Is endoscopic papillary balloon dilatation really a risk factor for post-ERCP pancreatitis?

Authors:  Toshio Fujisawa; Koichi Kagawa; Kantaro Hisatomi; Kensuke Kubota; Atsushi Nakajima; Nobuyuki Matsuhashi
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

8.  Small sphincterotomy combined with endoscopic papillary large balloon dilation versus sphincterotomy.

Authors:  Hyun Gun Kim; Young Koog Cheon; Young Deok Cho; Jong Ho Moon; Do Hyun Park; Tae Hoon Lee; Hyun Jong Choi; Sang-Heum Park; Joon Seong Lee; Moon Sung Lee
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

9.  Endoscopic papillary large balloon dilatation alone is safe and effective for the treatment of difficult choledocholithiasis in cases of Billroth II gastrectomy: a single center experience.

Authors:  Hui Won Jang; Kyong Joo Lee; Moon Jae Jung; Joo Won Jung; Jeong Youp Park; Seung Woo Park; Si Young Song; Jae Bock Chung; Seungmin Bang
Journal:  Dig Dis Sci       Date:  2013-02-08       Impact factor: 3.199

10.  The increase in balloon size to over 15 mm does not affect the development of pancreatitis after endoscopic papillary large balloon dilatation for bile duct stone removal.

Authors:  Young Hoon Youn; Hyun Chul Lim; Jae Hoon Jahng; Sung Il Jang; Jung Hwan You; Jung Soo Park; Se Joon Lee; Dong Ki Lee
Journal:  Dig Dis Sci       Date:  2010-10-14       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.